Search

everythinglearnresearchcommunity

for

Search:↓

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

TG5 helps maintain hair follicle health, while TG3 aids in hair shaft development.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

CGF from platelets helps hair regrowth in people with androgenetic alopecia.

RCS-01 cell therapy is safe and improves skin gene expression.

The rhg mutation in mice affects the Oat gene, causing hair growth issues and other symptoms.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Human and mouse TGase3 enzymes are similar but differ near the activation site, crucial for their function in skin and hair development.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

ASLNC168501 may help treat hair loss by boosting hair follicle stem cell activity.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

GasderminA3 is important for normal hair cycle transitions by controlling Wnt signaling.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

ITK inhibitors may effectively treat alopecia areata.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Activated protein C helps protect mice from radiation damage.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.